Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies
| Title: | Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies |
|---|---|
| Authors: | Ansell, Stephen M., Flinn, Ian, Taylor, Matthew H., Sikic, Branimir I., Brody, Joshua, Nemunaitis, John, Feldman, Andrew, Hawthorne, Thomas R., Rawls, Tracey, Keler, Tibor, Yellin, Michael J. |
| Source: | In Blood Advances 12 May 2020 4(9):1917-1926 |
| Database: | ScienceDirect |
| ISSN: | 24739529 |
|---|---|
| DOI: | 10.1182/bloodadvances.2019001079 |
| Published in: | Blood Advances |
| Language: | English |